liposomal bpc 157 kpv and Summit Health- Functional Medicine Pratice Regeneration or Risk? A Narrative
Description
IS IGF-1LR3 SAFE
Phase Titration Dose 75 mg Frequency 1-3x weekly Notes Increase by ~25 mg if assessment phase is well tolerated
Definitely will order again and will try other injections as well
If more doses are taken, the dose should be reduced for each dose
However, blinded adjudication of the above studies 192 revealed that osteonecrosis was not primary in these cases, but tanezumab treatment was associated with an increase in the rapid progression of osteoarthritis
Have subtle structural issues affecting function
